|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113 IDR | -4.24% |
|
-14.39% | -90.13% |
| May. 10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| Mar. 15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Pyridam Farma Tbk reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 550,922.64 million compared to IDR 406,374.39 million a year ago. Net income was IDR 288,756.94 million compared to IDR 15,964.15 million a year ago.
Basic earnings per share from continuing operations was IDR 539.65 compared to IDR 29.84 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.13% | 77.91M | |
| +43.83% | 749B | |
| +39.42% | 605B | |
| -6.57% | 351B | |
| +19.44% | 328B | |
| +7.90% | 292B | |
| +11.72% | 216B | |
| -2.49% | 214B | |
| +1.74% | 167B | |
| +7.11% | 165B |
PT PYRIDAM FARMA TBK 
